NUVALENT INC-A (NUVL)
US6707031075 - Common Stock
ChartMill assigns a Buy % Consensus number of 89% to NUVL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 103.53. This target is 42.52% above the current price.
NUVL was analyzed by 16 analysts. The buy percentage consensus is at 89. So analysts seem to be very confident about NUVL.
In the previous month the buy percentage consensus was at a similar level.
NUVL was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-17 | Jefferies | Initiate | Buy |
| 2024-04-01 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2024-03-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-02-28 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-02-23 | Baird | Initiate | Outperform |
| 2023-10-19 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-10-05 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-10-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-10-04 | Stifel | Reiterate | Buy |
| 2023-09-27 | Stifel | Initiate | Buy |
| 2023-08-08 | SVB Leerink | Initiate | Market Perform |
| 2023-07-24 | Guggenheim | Initiate | Buy |
| 2023-07-20 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-06-23 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-01-18 | Wedbush | Initiate | Outperform |
| 2022-06-24 | BMO Capital | Initiate | Outperform |
| 2021-08-23 | Cowen & Co. | Initiate | Outperform |
| 2021-08-23 | JP Morgan | Initiate | Overweight |
| 2021-08-23 | Piper Sandler | Initiate | Overweight |